faculty

Projects

Home / Projects / GS - US - 174-0144. A Randomized double blinded evaluation of the antiviral efficacy safety and tolerability of Tenofovir Disproxil Furmarate versus placebo in paediatric patient with chronic hepatitis B infection. IEC Ref. No. 359/2015 Study started Date: 25/05/2016 GS - US - 174-0144. A Randomized double blinded evaluation of the antiviral efficacy safety and tolerability

GS - US - 174-0144. A Randomized double blinded evaluation of the antiviral efficacy safety and tolerability of Tenofovir Disproxil Furmarate versus placebo in paediatric patient with chronic hepatitis B infection. IEC Ref. No. 359/2015 Study started Date: 25/05/2016 GS - US - 174-0144. A Randomized double blinded evaluation of the antiviral efficacy safety and tolerability

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2016 - 2025

Project Lead

Authors

Dr. Harshad Devarbhavi & Dr. Mallikarjun

Project Status

ongoing